Atlas Trials

An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

Clinical trial NCT03972501 · COMPLETED

Trial details

NCT number
NCT03972501
Sponsor
Azura Ophthalmics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Meibomian Gland Dysfunction (MGD)Contact Lens Discomfort (CLD)
Start date
2019-10-04
Primary completion
2020-12-11
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.